A young British woman who used to drink 12 cups of coffee a day and quit because of some caffeine withdrawal symptoms like severe headaches was diagnosed with grade three oligodendroglioma—a type of ...

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative tr ...

New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Bi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat ...

The people involved in the study have rare genetic mutations, making it nearly certain they will develop Alzheimer's. AP reports on how mass firings and funding restrictions at the NIH are affecting ...

At the young age of 2, Gavin Nielsen was diagnosed with a rare and aggressive brain cancer called diffuse intrinsic pontine glioma (DIPG). This type of cancer affects the part of the brain stem ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

A recent study published in MedComm – Future Medicine by a research team from Fudan University provides an in-depth ...

By singling out a protein they say is involved in the growth of glioblastoma, scientists say they can create targeted ...